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The contribution of psychological disorders to the burden of skin disease has been poorly explored, and this is a
large-scale study to ascertain the association between depression, anxiety, and suicidal ideation with various
dermatological diagnoses. This international multicenter observational cross-sectional study was conducted in
13 European countries. In each dermatology clinic, 250 consecutive adult out-patients were recruited to complete
a questionnaire, reporting socio-demographic information, negative life events, and suicidal ideation; depression
and anxiety were assessed with the Hospital Anxiety and Depression Scale. A clinical examination was performed.
A control group was recruited among hospital employees. There were 4,994 participants––3,635 patients and 1,359
controls. Clinical depression was present in 10.1% patients (controls 4.3%, odds ratio (OR) 2.40 (1.67–3.47)).
Clinical anxiety was present in 17.2% (controls 11.1%, OR 2.18 (1.68–2.82)). Suicidal ideation was reported by 12.7%
of all patients (controls 8.3%, OR 1.94 (1.33–2.82)). For individual diagnoses, only patients with psoriasis had
significant association with suicidal ideation. The association with depression and anxiety was highest for patients
with psoriasis, atopic dermatitis, hand eczema, and leg ulcers. These results identify a major additional burden of
skin disease and have important clinical implications.
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INTRODUCTION
Despite the high prevalence of skin conditions (Rea et al.,
1976; Dalgard et al., 2004) and the strong association of
psychiatric disorders with skin disease (Hughes et al., 1983,
Picardi et al., 2000), the true extent of psychological co-
morbidity across Europe is not known. This is important
because the care of patients with skin disease may be
inadequate if their psychological problems are not also
recognized and treated.
The Global Burden of Diseases Study recently demonstrated
that skin diseases were the fourth leading cause of nonfatal
disease burden (Hay et al., 2014). Assessing the burden of skin
disease is crucial for evidence-based allocation of resources
and to position Dermatology in a global health perspective
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(Freeman, 2014), but the choice of appropriate method
remains a challenge. A wider perspective of the burden of
physical conditions is demonstrated by the significant
occurrence of depression in diabetes, asthma, heart disease,
and arthritis (Scott et al., 2007). It is predicted that depressive
disorder will be the second cause of disease burden
worldwide by 2030 (Mathers and Loncar, 2006), and the
contribution of mental health to the burden of physical
conditions is stressed in the context of the World Health
Organization strategies by their slogan ‘‘there is no health
without mental health’’ (Prince et al., 2007). The co-
occurrence of mood disorders and physical conditions has
been emphasized by the World Mental Health Survey (Scott
et al., 2007, 2010). Measurement of the mental health of
patients with physical diseases may therefore appropriately
contribute to the overall measurement of the burden of
disease.
European studies have shown that patients with atopic
eczema, hand eczema, acne, and hidradenitis suppurativa
have an increased risk of depression (Cvetkovski et al., 2006;
Dalgard et al., 2008; Onderdijk et al., 2013; Sanna et al.,
2014a), and 10% of patients with psoriasis are clinically
depressed (Dowlatshahi et al., 2013). Although anxiety is a
separate entity, it is less studied and mostly described as
accompanying depression in dermatological patients with
psoriasis and occupational eczema (Boehm et al., 2012;
Kurd et al., 2010). Population-based studies have shown
significant associations of acne, eczema, and psoriasis with
suicidal thoughts (Kurd et al., 2010; Halvorsen et al., 2011,
2014). In a study from Germany, 16% of patients with atopic
dermatitis had suicidal ideation compared with 1% of the
controls (Dieris-Hirche et al., 2009).
Little is known about psychological co-morbidity of com-
mon skin diseases from a global perspective. The aim of this
study was to investigate the co-occurrence of depression,
anxiety, and suicidal thoughts in patients with common skin
diseases across several European countries.
RESULTS
In total, 5,067 individuals agreed to take part––3,651 patients
and 1,416 controls. The participation rate was 79.9%. Of the
initial 3,651 patients, 16 were excluded, 9 because they were
too young and 6 because of missing data, leaving 3,635. Of
the initial 1,416 controls, 57 were excluded because they had
a skin disease, leaving 1,359 (see flow chart).
The subject characteristics are given in Table 1: there were
more females in both the patient and control populations. The
mean patient age was 47 years versus 41 years for the
controls, Po0.001. Overall 92% participants originated from
the country where the study took place (data not shown). The
socio-economic level distribution was similar in the two
groups. Overall 35.6% of the patients reported stress com-
pared with 30.6% of the controls, Po0.001. Overall patients
had more physical co-morbidities compared with the controls,
28.8% versus 16.0%, Po0.001.
The overall distribution of the skin conditions is given in
Table 2. The most common skin conditions were as follows:
psoriasis (17.4%), non-melanoma skin cancer (10.9%),
infections of the skin (6.8%), eczema (6.4%), acne (5.9%),
nevi (4.9%), atopic eczema (4.5%), skin tumors (4.2%), hand
eczema (4.0%), and leg ulcers (3.4%).
Data on depression among dermatological patients are
given in Table 3. Overall 10.1% dermatological patients were
clinically depressed compared with 4.3% controls (Po0.001,
adjusted OR 2.40, 95% confidence interval (CI) 1.67–3.47).
The highest adjusted OR for depression were found among
patients with leg ulcers (OR 10.17, 95% CI 4.07–25.41), hand
eczema (OR 4.00, 95% CI 2.01–7.97), atopic dermatitis (OR
3.27, 95% CI 1.61–6.62), psoriasis (OR 3.02, 95% CI 1.86–
4.90), and infections of the skin (OR 2.65, 95% CI 1.39–5.06).
Table 1. Characteristics of study population, N¼ 4,994
Patients
N¼3,635
N (%)
Controls
N¼1,359
N (%) P-value
Countries
Belgium 248 (6.8) 131 (9.6) —
Denmark 256 (7.0) 122 (9.0) —
France 114 (3.1) 20 (1.5) —
Germany 278 (7.6) 133 (9.8) —
Hungary 250 (6.9) 134 (9.9) —
Italy (two centers) 499 (13.7) 46 (3.4) —
Netherlands 213 (5.9) — —
Norway (two centers) 527 (14.5) 218 (16.0) —
Poland 250 (6.9) 125 (9.2) —
Russia 248 (6.8) 120 (8.8) —
Spain 249 (6.9) 116 (8.5) —
Turkey 250 (6.9) 109 (8.0) —
UK 253 (7.0) 85 (6.3) —
Gender (MD¼ 17)
Females 2,045 (56.5) 903 (66.6) o0.001
Age years Mean SD (MD¼ 91) 47.2 (SD¼ 17.9) 41.1 (SD¼13.6) o0.001
Females 46.0 (SD¼ 17.6) 41.1 (SD¼13.3) o0.001
Males 48.6 (SD¼ 18.2) 41.1 (SD¼14.2) o0.001
Marital status (MD¼ 322)
Single 863 (26.0) 362 (26.7) o0.001
Married/partner 1,978 (59.6) 840 (62.0) —
Separated/divorced 273 (8.2) 119 (8.8) —
Widowed 203 (6.1) 34 (2.5) —
Self-reported socioeconomic level (MD¼ 106)
Low 644 (18.2) 215 (15.9) 0.183
Middle 2,589 (73.1) 1,012 (75.1) —
High 307 (8.7) 121 (9) —
Stressful life events during last 6 months (MD¼ 97)
Yes 1,262 (35.6) 412 (30.6) o0.001
Physical co-morbidities1 (MD¼ 479)
Yes 993 (28.8) 170 (16.0) o0.001
Abbreviation: MD, missing data.
1Physical co-morbidities: any treated cardio-vascular, chronic respiratory,
diabetes, or rheumatologic disease.
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Table 4 gives data on anxiety in patients with common skin
diseases. Overall, anxiety affected 17.2% of the patients
compared with 11.1% of the controls (Po0.001, adjusted
OR 2.18, 95% CI 1.68–2.82). The highest adjusted OR for
anxiety disorders were found among patients with psoriasis
(OR 2.91, 95% CI 2.01–4.21), leg ulcers (OR 2.80, 95% CI
1.18–6.64), hand eczema (OR 2.60, 95% CI 1.45–4.67), and
acne (OR 2.53, 95% CI 1.40–4.58).
Suicidal ideation in common skin conditions is described in
Table 5. Overall 12.7% of the dermatological patients
reported suicidal ideation compared with 8.3% of the controls
(Po0.001, adjusted OR 1.24, 95% CI 0.95–1.62). Only
patients with psoriasis had a significant association with
suicidal thoughts (OR 1.94, 95% CI 1.33–2.82). Of the
patients reporting overall suicidal ideation, 53.6% reported
that the suicidal thoughts were because of their skin condition:
specifically 67.6% of patients with psoriasis and 68.0% of
patients with atopic dermatitis reported suicidal ideation
because of their skin.
DISCUSSION
We found a significantly higher prevalence of clinical depres-
sion (10.1% vs. 4.3%), anxiety disorder (17.2% vs. 11.1%),
and suicidal ideation (12.7% vs. 8.3%) among patients with
common skin diseases compared with controls. These find-
ings, from a wide geographical, cultural, and socio-economic
base, have relevance for clinical services across Europe
(Aguilar-Duran et al., 2014) because of the high prevalence
of skin diseases.
The reference values in our control group are in accordance
with estimations of the European prevalence of mental dis-
orders (Wittchen et al., 2011). The co-occurrence of mental and
dermatological problems has previously mostly been described
in national single center studies. An Italian study of 2,579
dermatological patients showed an overall psychiatric morbi-
dity of 25%, with a higher percentage of psychiatric cases in
patients with skin infections, pruritic conditions, and alopecia
(Picardi et al., 2000). However, the General Health Question-
naire used in both studies does not specifically measure
depression and anxiety, as it does not measure symptoms of
distress. Therefore, the Hospital Anxiety and Depression Scale
(HADS) seems more appropriate to use: this instrument has
shown solid psychometric properties regarding factor analysis
and internal consistency. Although there is a shared variance of
30% of the subscales of depression and anxiety, the sensi-
tivity and specificity for the anxiety and depression subscales
are high, which allows separation of anxiety disorder from
depression (Mykletun et al., 2001; Bjelland et al., 2002; Picardi
et al., 2005; Breeman et al., 2014).
The interpretation of previous published work is often made
difficult because of a lack of prospective control group data,
with many studies relying on population reference values. Our
results are, however, compatible with a Danish study using the
Beck Depression Inventory that reported a depression pre-
valence of 13% in dermatological patients compared with 5%
among controls (Zachariae et al., 2004).
Patients with leg ulcers had the highest rates of depression,
and this association remained strong in the regression analysis.
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These results confirm the psycho-social aspects of chronic leg
ulcers: patients with chronic leg ulcers are often depressed
and isolated (Moffatt et al., 2009). We found an increased
prevalence of depression among patients in the subgroup of
eczema and atopic eczema and a higher odds ratio (OR) for
depression in patients with atopic eczema. These findings
correspond to those of Australian and Finish studies (Timonen
et al., 2003; Sanna et al., 2014a). Hand eczema formed a
separate subgroup of eczema that also showed an indepen-
dent and high score for depression, again in concordance with
previous studies (Niemeier et al., 2002; Cvetkovski et al.,
2006; Boehm et al., 2012).
Table 3. Depression in patients with common skin diseases and controls in percentages and ORs (95% confidence
interval) N¼ 4,994
Diagnosis
Depression clinical case
HADSX11% (n) P-value
Crude OR1 depression
clinical case HADS411
Adjusted OR2 depression
clinical case HADS411
Psoriasis 13.8 (84) o0.001 3.23 (2.06–5.05) 3.02 (1.86–4.90)
Non-melanoma skin cancer 4.8 (18) 0.729 1.21 (0.62–2.36) 0.97 (0.41–2.32)
Infections skin 8.9 (21) 0.001 2.59 (1.40–4.76) 2.65 (1.39–5.06)
Eczema 8.0 (18) 0.007 1.79 (0.89–3.59) 1.68 (0.80–3.53)
Acne 5.7 (12) 0.311 1.53 (0.74–3.13) 1.74 (0.73–4.17)
Nevi 6.0 (11) 0.215 2.05 (0.99–4.22) 2.14 (1.01–4.53)
Atopic eczema 10.1 (16) o0.001 3.55 (1.82–6.92) 3.27 (1.61–6.62)
Benign skin tumors 4.8 (7) 0.587 1.50 (0.69–3.65) 1.43 (0.55–3.74)
Hand eczema 15.1 (21) o0.001 4.85 (2.59–9.10) 4.00 (2.01–7.97)
Leg ulcers 24.3 (28) o0.001 11.23 (5.71–22.09) 10.17 (4.07–25.41)
Dermatological out-patients overall 10.1 (357) o0.001 2.69 (1.88–3.84) 2.40 (1.67–3.47)
Controls 4.3 (58) — 1 1
Abbreviations: HADS, hospital anxiety and depression scale; MD, missing data; OR, odds ratio.
Missing data hospital anxiety depression scale-depression¼ 109 (patients¼ 102; controls¼7).
1Without participants with missing data for one or more of the predictors.
2Regression model for each disease separately, adjusting for gender, age, socio-economic status, stress, and co-morbidity.
Table 4. Anxiety in patients with common skin diseases and controls in percentages and OR (95% confidence
interval) N¼ 4,994
Diagnosis
Anxiety clinical case
HADS411% (N) P-value
Crude OR1 anxiety clinical
case HADS411
Adjusted OR2 anxiety clinical
case HADS411
Psoriasis 22.7 (139) o0.001 2.79 (2.02–3.85) 2.91 (2.01–4.21)
Non-melanoma skin cancer 8.0 (30) 0.066 0.85 (0.52–1.90) 1.17 (0.60–2.27)
Infections skin 13.2 (31) 0.179 1.59 (0.97–2.61) 1.61 (0.93–2.78)
Eczema 16.7 (37) 0.013 1.78 (1.09–2.82) 1.73 (1.01–2.93)
Acne 15.1 (32) 0.013 2.23 (1.41–3.52) 2.53 (1.40–4.58)
Nevi 11.2 (19) 0.902 1.23 (0.69–2.20) 1.32 (0.70–2.47)
Atopic eczema 17.6 (28) 0.006 2.29 (1.34–3.92) 2.01 (1.10–3.68)
Benign skin tumors 10.9 (16) 0.753 1.44 (0.78–2.63) 1.59 (0.80–3.15)
Hand eczema 21.0 (29) o0.001 2.93 (1.74–4.93) 2.60 (1.45–4.67)
Leg ulcers 17.5 (20) 0.011 2.75 (1.39–5.44) 2.80(1.18–6.64)
Dermatological out-patients overall 17.2 (607) o0.001 2.15 (1.69–2.75) 2.18 (1.68–2.82)
Controls 11.1 (150) — 1 1
Abbreviations: HADS, hospital anxiety and depression scale; MD, missing data; OR, odds ratio.
Missing data HADS-anxiety¼ 116 (patients¼107; controls¼9).
1Without participants with missing data for one or more of the predictors.
2Regression model for each disease separately, adjusting for gender, age, socio-economic status, stress, and co-morbidity.
FJ Dalgard et al.
Psychological Burden of Skin Diseases
www.jidonline.org 987
The highest rate of anxiety was reported in patients with
psoriasis and hand eczema. The prevalence of depression
among psoriasis patients and the significant OR of 3.02 are in
accordance with a recent meta-analysis of 98 studies, showing
that 410% of psoriasis patients have clinical depression
(Dowlatshahi et al., 2013). Our finding of anxiety in 17% of
patients is higher compared with the findings of a global
longitudinal study on psoriasis showing anxiety in 11% of
patients (Kimball et al., 2014) but in accordance with a recent
study of psoriasis patients from Canada using the HADS
(McDonough et al., 2014). The rates of anxiety we found in
patients with hand eczema were in agreement with a German
study among 122 patients, also using the HADS, showing a
20% prevalence of anxiety (Boehm et al., 2012).
By separating anxiety and depression some additional
relevant observations have been made possible. Patients with
acne have significantly more anxiety compared with the
controls, but are not depressed, and patients have an OR42
for clinical anxiety. Although a previous study showed a
significant increased association between acne and mental
distress, our findings are relevant (Halvorsen et al., 2011).
Suicidal thoughts were only significantly associated with
psoriasis. This is in accordance with the study of Gupta
et al., (1993) among patients with psoriasis but in contrast to
a recent study examining suicidal ideation in 907 men with
physical illnesses, which did not find significant association
with psoriasis in a model controlling for depression (Sanna
et al., 2014b). In our study, the increased rates of suicidal
ideation for other skin conditions were not significant,
suggesting that in our sample suicidal thoughts are
secondary to other factors such as depression. It is possible
that the ‘‘yes’’ or ‘‘no’’ response choice might have resulted in
a higher recording of suicidal ideation. Nevertheless, the
original aspect in this present study is that patients were
specifically asked about suicidal ideation caused by skin
symptoms.
This study has several strengths: first, the large European
sample studied is a cross-section of dermatological out-
patients. The breadth of diseases included and their widely
differing psycho-social backgrounds provide robust overall
data that compensate for some limitations by reflecting the
reality of the populations served. Second, the presence of the
control group enables us to compare the outcome variables
with a reference population that is more appropriate than
comparison to other patient groups. Finally, the high partici-
pation rate adds to the robustness of the study.
However, the study has several limitations. The study design
did not allow face-to-face clinical interviews for confirmation
of diagnosis of mental illness. However, the psychometric
approach to evaluate depression used a self-administrated
scale with strong psychometric properties.
There were differences in the prevalence of skin diseases
from center to center. Although we planned to recruit only
from clinics with general dermatology consultations, our data
probably reflect some recruitment bias. There may have been
bias in the selection of patients due to differences in the
referral systems and organization of the clinics. Although all
study centers have a special interest in psycho-dermatology,
the small number of specific psycho-dermatological diagnoses
(n¼ 22) confirms that the sample came from general out-
patients. By merging the whole data, we presume that the
overall diagnosis distribution reflects that seen in any general
out-patient clinic. This is supported by our prevalence data
being comparable to a UK population survey on the
Table 5. Suicidal ideation in patients with common skin diseases and controls in percentages and OR (95%
confidence interval) N¼ 4,994
Diagnosis
Suicidal
ideation
overall % (N) P-value
Suicidal ideation because
of skin disease (among
those with suicidal
ideation overall) %(N)
Suicidal ideation
because of skin disease
(in the whole
sample) %(N)
Crude OR1
suicidal
ideation
Adjusted OR2
suicidal ideation
Psoriasis 17.3 (106) o0.001 67.6 (71) 11.6 (71) 2.21 (1.59–3.07) 1.94 (1.33–2.82)
Non-melanoma skin cancer 6.9 (26) 0.393 30.4 (7) 1.9 (7) 0.72 (0.42–1.24) 1.60 (0.78–3.29)
Infections skin 8.9 (21) 0.760 33.3 (7) 2.9 (7) 0.69 (0.36–1.33) 0.56 (0.28–1.11)
Eczema 9.3 (21) 0.623 61.9 (13) 5.7 (13) 0.93 (0.52–1.65) 0.92 (0.50–1.70)
Acne 12.3 (26) 0.058 40.0 (10) 4.7 (10) 1.47 (0.90–2.39) 1.01 (0.56–1.83)
Nevi 12.9 (22) 0.049 50.0 (11) 6.4 (11) 1.46 (0.84–2.55) 1.52 (0.84–2.72)
Atopic eczema 15.0 (25) 0.002 68.0 (17) 10.6 (17) 2.03 (1.20–3.45) 1.32 (0.75–2.33)
Benign skin tumors 11.3 (17) 0.208 52.9 (9) 6.0 (9) 1.16 (0.62–2.20) 1.21 (0.61–2.41)
Hand eczema 14.2 (20) 0.020 45.0 (9) 6.4 (9) 1.49 (0.82–2.73) 1.08 (0.57–2.08)
Leg ulcers 17.8 (21) o0.001 47.6 (10) 8.4 (10) 2.04 (1.03–4.04) 1.27 (0.54–2.99)
Dermatological out-patients (all) 12.7 (451) o0.001 53.6 (238) 6.7 (238) 1.46 (1.13–1.88) 1.24 (0.95–1.62)
Controls 8.3 (88) — — — 1 1
Abbreviation: OR, odds ratio.
1Without participants with missing data for one or more of the predictors.
2Regression model for each disease separately, adjusting for gender, age, socio-economic status, stress, co-morbidities, and depression.
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distribution of skin disease (Rea et al., 1976). The study can be
considered to be naturalistic and representative of derma-
tological out-patients in general, but the representativeness of
the populations studied should be interpreted with care.
Length-biased sampling is potentially of concern for a study
occurring over time, but it is suggested that the chronic non-
lethal nature of the diseases studied limits that risk. The use of
healthy, employed controls may introduce a bias; however, this
is partly intended, as the control group reflects the desired state
of health more closely than for example a group of other patients
and because it allows more immediate comparison with other
similar studies. For practical reasons the control group overall
was smaller compared with the patient group, but this did not
affect the results of the regression analysis. Furthermore, patients
with severe mental disease were excluded, reducing the risk of
bias. However, clinical data were not recorded and uncontrolled
confounding factors such as disease severity, treatment, disease
localization, or pruritus may have influenced patients’ percep-
tion of their disease and hence the study results. The cross-
sectional design of the study does not allow interpretation of the
direction or causality of the associations between the skin
diseases and the psychological outcomes.
This large European multicenter study demonstrates that
adult patients with common skin diseases such as psoriasis,
atopic dermatitis, hand eczema, and leg ulcers have signifi-
cant psychological co-morbidities. These results identify a
major additional burden of skin disease and have important
clinical implications.
MATERIALS AND METHODS
Study design
This investigation was an observational cross-sectional multicenter
study (for additional information see STROBE Supplementary Text
in the JID homepage). Patients were recruited from dermatological
out-patient clinics in 13 European countries from November 2011 to
February 2013. Dermatology departments from the following centers
participated: Erasmus Hospital, Brussels (Belgium), University of
Copenhagen, Roskilde Hospital (Denmark), Brest University Hospital
(France), Justus-Liebig University (Germany), University of Szeged
(Hungary), University of Padua Medical School (Italy), Istituto
Dermopatico dell’Immacolata, Rome (Italy), Radboud University
Medical Center, Nijmegen (The Netherlands), Oslo University
Hospital and Stavanger University Hospital (Norway), Wroclav
Medical University, Wroclaw (Poland), Moscow Medical Academy
IM Sechenov (Russia), Aragon Health Sciences Institute, Alcaniz
Hospital (Spain), Sisli Etfal Teaching and Research Hospital, Istanbul
(Turkey), and Cardiff University (UK). Two countries (Norway and
Italy) had two centers of collection in different parts of the country.
Ethics
The study protocol was approved by the Regional Committee for
Medical Research Ethics in Norway REK 2011/1087. Local ethical
approval was obtained where necessary. The study was conducted in
accordance with the Declaration of Helsinki.
Settings
At each dermatological out-patient clinic, consecutive patients were
invited to participate in the study on one or more random days until
250 were reached. The inclusion criteria were age 418 years, being
able to read and write the local language, and not suffering from
severe psychosis, to reflect the majority of patients and avoid any
overestimation of any possible co-occurrence between mental and
skin disease. Each participant completed a questionnaire and gave it
to the consultant before being examined clinically.
Each patient was examined by a dermatologist who recorded the
diagnosis; if required a secondary diagnosis was recorded. The
presence of other physical conditions was recorded: cardio-vascular
disease, chronic respiratory disease, diabetes, and rheumatologic
disease. If there were doubts as to whether a skin disease was present
(eg, no diagnosis, no flares, and no itch) the patients were not
included in the sample.
In each center, a control group of at least 125 subjects were
recruited by advertisement from among hospital employees at the
same institution but not from the same department. Only those
willing to participate were included. Employees with a skin condition
were excluded. The employees were informed about the study and
invited to answer the questionnaire after giving written consent. The
subjects were not examined. Information on treated co-morbidities
was self-reported. All participants were informed and gave signed
consent.
Questionnaires
The first part of the questionnaire recorded socio-demographic variables
including self-reported socio-economic status. Ethnicity was self-
assigned by each participant referring to their own country of birth.
Stress was assessed with the item ‘‘Have you had any stressful life events
during the last 6 months?’’ with a possible answer of ‘‘yes’’ or ‘‘no’’.
Symptoms of depression and anxiety, the main outcome variables,
were assessed with the HADS, a well-validated instrument showing
good psychometric properties, to assess severity and presence of
anxiety disorders and depression in somatic, psychiatric, and primary
care patients, as well as in the general population (Zigmond and
Snaith, 1983; Mykletun et al., 2001; Bjelland et al., 2002). HADS
includes seven items assessing anxiety and seven for depression, each
with four possible answers. For each dimension of anxiety and
depression a score from 0 to 7 is considered a normal case, from 8
to 10 a borderline case, and from 11 to 21 a case in need of further
examination or treatment. This instrument was used in the validated
translations relevant to the study countries.
To assess suicidal ideation, we included the item ‘‘Have you ever
thought of committing suicide?’’ with possible answers ‘‘yes’’ or
‘‘no’’: we were not able to identify a validated item on suicidal
ideation. An additional question was given to the patient group:
‘‘Have you ever thought of committing suicide because of your skin?’’
with an item on frequency when the answer was yes.
Statistical analysis
The statistical power was calculated on the basis of the prevalence of
depression in the general population estimated as 9% and the
expected prevalence in the dermatological population being higher
(Hinz and Brahler, 2011; Breeman et al., 2014). However, as our
cases were nonselected out-patients with several skin conditions at
various degrees of severity, we expected to find a lower prevalence.
To identify a difference with a power of 0.80 and alpha¼ 0.05
between a prevalence of depression of 9% in controls and 11% in
cases, using a one-sided test, 3,500 cases and 1,300 controls were
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needed (about 233 cases and 87 controls in each center). The data
were entered in an SPSS or Excel database at each site, after
completion of data collection (IBM Corp. Released 2013. IBM SPSS
Statistics for Windows, Version 22.0, Armonk, NY). Ten sets of
questionnaires from each center were sent to the Statistical Center
(Institute of Medical Psychology, University of Giessen, Germany, not
a recruiting center) to ensure that the data had been entered in a
standardized way. The final data were merged in a single file and
checked and cleaned. The diagnoses given in different European
languages were translated by the dermatologists from the study team
to diagnoses from the International Classification of Disease version
10. If needed, national centers were consulted.
The dermatological diagnoses were organized into 26 categories
adapted from the Lambeth study (Rea et al., 1976). Data were used
only if the diagnostic group included at least 100 patients, 10
diagnoses fulfilled this criterion, and hence we performed the
analysis on the 10 most prevalent diagnostic categories from the
total sample. The diagnostic categories with o100 patients included
a large range of dermatological conditions; results are not shown.
SPSS version 22 software (IBM Corp. Released 2013. IBM SPSS Statis-
tics for Windows, Version 22.0) was used to analyze the data. To charac-
terize the study population, we report numbers, percentage, or mean
values with standard deviation. To compare the patients and the controls,
we used the t-test for continuous variables and the w2-test for dichoto-
mous or categorical variables. We describe the prevalence of depression,
anxiety, and suicidal ideation with percentages and numbers.
To compare the prevalence between the disease groups and the
controls, we used the w2-test for dichotomous variables. Multivariate
logistic regression models were tested to study the associations
between main outcome variables (depression, anxiety, and suicidal
ideation) and groups (patients and controls). The regression models
were calculated for each disease separately, adjusting for gender, age,
socio-economic status, stress, and co-morbidity.
The ORs were calculated from the estimated regression coefficients
B from the logistic regressions. The exponential of the coefficient
gives the OR. In the first step, we calculated the crude ORs and in the
second adjusted ORs simultaneously controlling for potential con-
founding factors (gender, age, socio-economic status, perceived
stress, co-morbidities, depression (only for the logistic regression for
suicidal ideation) with a 95% CI.
In the regression models the Netherlands, France, and Italy centers
were excluded because no controls were recruited at these centers.
Other analyses were performed with the complete data set. Cases
with missing data for single variables were excluded from the analysis
when necessary.
The differences in the percentage of diagnoses between the centers
represent the prevalence of diagnoses in different countries. These
differences were accepted as reflecting the real life situation in
different populations of dermatological out-patients: for instance,
Turkey has more acne patients, as a result of the younger average
age of the population in Turkey.
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